Inicio › Cáncer de próstata › Oregón
Ensayos clínicos de Cáncer de próstata en Oregón
38 estudios sobre Cáncer de próstata buscan participantes en Oregón.
Ciudades en Oregón
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Providence Newberg Medical Center, Newberg
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Willamette Falls Medical Center, Oregon City
- y 3 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
ReclutandoFase 4
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07569926cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- y 7 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06095089Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07200830A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 26 oct 2026 · NCT05593497Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
ReclutandoEstudio observacional
Edades de 18 a 120 · Hombres · Actualizado el 26 oct 2026 · NCT04706663Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 oct 2026 · NCT07611110A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 16 oct 2026 · NCT06879041Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Portland
- Research Site, Portland
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 15 oct 2026 · NCT07711002Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
ReclutandoFase 1/2
Edades de 18 a 99 · Hombres · Actualizado el 14 oct 2026 · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06952803EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06049355FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 31 ago 2026 · NCT05726292Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 25 jun 2026 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 15 jun 2026 · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
ReclutandoEstudio observacional
Edades de 21 en adelante · Hombres · Actualizado el 22 may 2026 · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Hombres · Actualizado el 15 may 2026 · NCT04472338Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2026 · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Reclutando
Edades de 65 en adelante · Hombres · Actualizado el 6 may 2026 · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- y 9 más
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 29 ene 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 ene 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 20 abr 2022 · NCT03753243De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.